Syngen Biotech Market Cap

Syngen Biotech has a market cap or net worth of 3.44 billion as of April 4, 2025. Its market cap has decreased by -16.45% in one year.

Market Cap

3.44B

Enterprise Value

3.50B

Revenue

2.01B

Ranking

n/a

PE Ratio

14.35

Stock Price

127.00

Market Cap Chart

Since November 2, 2004, Syngen Biotech's market cap has increased from 372.00M to 3.44B, an increase of 825.22%. That is a compound annual growth rate of 11.51%.

Market Cap History

Date	Market Cap	% Change
Apr 2, 2025	3.44B	-
Dec 30, 2024	3.44B	-16.45%
Dec 29, 2023	4.12B	-6.17%
Dec 30, 2022	4.39B	43.36%
Dec 30, 2021	3.06B	4.63%
Dec 31, 2020	2.93B	-8.09%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	178.51B
Caliway Biopharmaceuticals	113.99B
Bora Pharmaceuticals Co., LTD.	71.78B
Lotus Pharmaceutical	61.56B
Oneness Biotech	32.98B
Lumosa Therapeutics	29.22B
Pegavision	28.08B
Polaris Group	27.65B

Market Cap Rankings